Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

The pharmaceutical industry is pushing back against Governor Cuomo's prescription drug price control proposal, arguing that it would lead to cuts in research. And they are pointing the finger at insurance companies and companies known as pharmacy benefit managers for the high costs paid by patients. Peter Pitts is a former FDA Associate Commissioner for External Relations and is now President of the Center for Medicine in the Public Interest.

 
Sign Up for Our Email Newsletter

RECENT NEWS

A high-stakes exam for healthcare leadership

A high-stakes exam for healthcare leadership

The blueprint and request for information make it clear that the healthcare status quo is no longer acceptable....  Read more

President Trump attacks symptom, not disease, in prescription drug price attack

President Trump attacks symptom, not disease, in prescription drug price attack

While it may be politically popular to blame drug prices for skyrocketing insurance costs, the president's claim doesn't ...  Read more

'It's the health care ecosystem, Stupid'

'It's the health care ecosystem, Stupid'

It’s high time we focused on the questionable practices of Pharmacy Benefit Managers....  Read more

DRUGWONKS BLOG